In the News

Share
1661 News Items found
Feature
Amy Speck
Robotic Neurosurgery at MSK Speeds Recovery From Some Spinal Tumors
MSK surgeons have regularly used robotic surgery since 2007 to remove certain tumors in the chest and abdominal cavity. Now they are using robotic surgery to remove noncancerous tumors of the spine.
In Brief
A sign outside the AACR meeting
AACR 2024 Research Highlights From MSK
MSK investigators presented new research on a range of important topics at the 2024 Annual Meeting of the American Association for Cancer Research.
Dana Pe'er
AACR: How Cellular Plasticity Drives Cancer Metastasis
In a plenary presentation at the 2024 American Association for Cancer Research (AACR) Annual Meeting, Dr. Dana Pe’er highlighted three recent research collaborations between her lab and other labs at MSK that have shed new light on the ability of cancer cells to adapt and spread.
Feature
Dr. Andrew Vickers
Myths About PSA Tests and Prostate Cancer Screening
PSA testing is an important part of screening for prostate cancer, when it’s used the right way. Learn the truth dispelling seven myths about the PSA test.
MSK physician-scientist Vinod Balachandran.
Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Andrea Barrio, a breast cancer surgeon at Memorial Sloan Kettering Cancer Center, talks to a patient
Important New Insights into Lymphedema: High Risk, Race, and Ethnicity
Learn about research on lymphedema at Memorial Sloan Kettering Cancer Center, which finds that Black and Hispanic women are at highest risk.
In the Clinic
Dr. Sandra D'Angelo
Immunotherapy Clinical Trial Shows Promise for Treating Rare Sarcomas
A new type of immunotherapy shows potential for treating some types of sarcoma — rare cancers of the body’s soft tissues.
A researcher working in an MSK lab
MSK Research Highlights, March 28, 2024
New MSK research shows the effectiveness of cryoablation for large breast cancer tumors; helps win the approval of a drug to treat one type of metastatic non-small cell lung cancer; identifies a gene essential for the formation of a common childhood brain tumor; and unlocks the secrets of natural killer cell metabolism.
Lisa-Erika James, who participates in MSK's Visible Ink, is seen smiling.
The Creativity of People Facing Cancer: Visible Ink Writing Program at MSK
 Fast FactsOver 3,000 people diagnosed with cancer have participated in Visible Ink.The program is free and open to MSK patients of any ageTo join...
Feature
MSK medical physicist Michael Bellamy
6 Myths about Radon and Lung Cancer
Learn about the connection between radon and the risk of lung cancer.